慢性异常性轴突神经病变:抗体,遗传学,以及其他方面
1Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Current opinion in neurology
|June 5, 2025
概括
最近在遗传学和新陈代谢方面的发现正在重新定义慢性异常性轴突神经病变 (CIAP). 索尔比托脱酶 (SORD) 缺乏和RFC1重复扩张现在是已知的原因,超越了"无病"的分类.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 慢性异常性轴突神经病变 (CIAP) 呈现出诊断挑战,由于未知原因,经常被标记为异常性.
- 进步正在揭示特定的遗传,代谢和免疫因素,这些因素以前被忽视.
研究的目的:
- 审查最近在理解CIAP方面取得的突破.
- 要突出新的遗传突变,自身抗体和代谢途径.
- 挑战传统的传统.
- 愚蠢的 愚蠢的 愚蠢的
- 这是CIAP的名称.
主要方法:
- 关于CIAP研究近期进展的文献综述.
- 专注于小纤维神经病变 (SFN) 的遗传突变 (SORD,RFC1) 和自身抗体.
- 分析新出现的代谢途径和潜在的治疗点.
主要成果:
- 双性SORD突变被确定为衰退性轴突神经病变的关键原因,使用阿尔多缩酶抑制剂 (ARIs) 进行潜在的治疗.
- RFC1内在重复扩张是CANVAS和感官神经病变的主要遗传原因.
- 在SFN中的自身抗体 (例如,TS-HDS,FGFR-3,Plexin D1) 表明免疫参与,尽管由于试验结果和测试限制,临床相关性仍在争论中.
结论:
- 基因和代谢方面的发现正在彻底改变CIAP的诊断和治疗.
- SORD缺陷,RFC1扩展和特定的自身抗体关联需要基于生物标志物的方法.
- 未来的研究应该优先考虑扩大基因查,改进免疫疗法和新型代谢调查,以准确诊断.
相关概念视频
Autoimmune Disorders
1.4K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.4K
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


